Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats

Author:

Xu Lijing1,Olivenstein Ronald1,Martin James G.1,Powell William S.1

Affiliation:

1. Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada H2X 2P2

Abstract

The objective of the present investigation was to examine the effects of an inhaled glucocorticoid, budesonide, on antigen-induced production of cysteinyl leukotrienes (cys-LTs) and pulmonary inflammatory cell infiltration in the Brown Norway rat, an animal model of asthma. Two weeks after sensitization to ovalbumin, rats were treated with budesonide (2.5 mg/kg) 18 and 1 h before challenge with antigen. Budesonide abolished the late response to ovalbumin ( P < 0.02) and strongly inhibited the in vivo synthesis of N-acetyl-leukotriene E4, an indicator of cys-LT synthesis, during this period ( P < 0.005). Both total bronchoalveolar lavage (BAL) cells ( P < 0.01) and BAL macrophages ( P < 0.005) were markedly reduced to ∼25% of their control levels after treatment with budesonide. It can be concluded that inhibition of the antigen-induced late response in Brown Norway rats by budesonide is associated with reductions in both BAL macrophages and cys-LT synthesis. It is possible that the effect of budesonide on cys-LT synthesis is related to its effects on pulmonary macrophages.

Publisher

American Physiological Society

Subject

Physiology (medical),Physiology

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Effects of Drugs on Air Ways;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Effects of Drugs on Air Ways;Drug Discovery and Evaluation: Pharmacological Assays;2015

3. Inhibitory effect of triamcinolone acetonide on synthesis of inflammatory mediators in the equine;European Journal of Pharmacology;2014-08

4. KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats;Journal of Cellular and Molecular Medicine;2012-12

5. Small animals models for drug discovery;Pulmonary Pharmacology & Therapeutics;2011-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3